Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Adv Ther. 2018 Nov;35(11):1842-1858. doi: 10.1007/s12325-018-0820-z. Epub 2018 Oct 29.
The Sarcopenia Quality of Life (SarQoL) questionnaire was developed to provide a patient-reported outcome measure specific to sarcopenia. Its psychometric properties indicate that it is a valid and reliable instrument. However, until now, its ability to detect change over time has not been examined. Therefore, the objective of this study is to evaluate the responsiveness (also known as sensitivity to change) of the SarQoL questionnaire in a prospective, longitudinal cohort of community-dwelling, older, sarcopenic subjects.
Sarcopenic subjects from the SarcoPhAge (Sarcopenia and Physical impairment with advancing Age) study were included. Responsiveness was evaluated with nine pre-specified hypotheses on the correlation between the evolution of the SarQoL scores after a 2-year interval and the evolution of the scores on the Short Form-36 (SF-36) and the Euroqol 5-dimension (EQ-5D) questionnaires. This technique considers responsiveness to be a form of longitudinal validity. Additionally, standardized response means were also calculated to compare the quantity of change measured by the different questionnaires.
A total of 42 sarcopenic subjects were included. The median age of the sample was 72.9 (68.9-78.8) years, 59.5% were female, and the mean body mass index was 23.3 (20.4-25.7) kg/m. A good responsiveness was observed, as evidenced by the confirmation of eight out of nine hypotheses, well above the 75% confirmation threshold. The standardized response mean of the Overall SarQoL score was significantly higher than those of the SF-36 Physical Component Summary (p = 0.005), the EQ-5D Utility Index (p < 0.001) and the Euroqol visual analogue scale (p = 0.003).
The first data available on the ability of the SarQoL questionnaire to detect change over time indicates that the questionnaire has good responsiveness. This, together with the previously established psychometric properties, confirms that the SarQoL questionnaire is a relevant instrument for the assessment of quality of life in sarcopenic populations.
肌肉减少症生活质量(SarQoL)问卷是为提供专门针对肌肉减少症的患者报告结局测量工具而开发的。其心理测量学特性表明,它是一种有效且可靠的工具。然而,到目前为止,其随时间变化的检测能力尚未得到检验。因此,本研究的目的是评估 SarQoL 问卷在社区居住的、年龄较大的、患有肌肉减少症的前瞻性纵向队列中的反应能力(也称为对变化的敏感性)。
纳入 SarcoPhAge(肌肉减少症和身体损伤与年龄增长)研究中的肌肉减少症受试者。通过九个预设假设来评估反应能力,这些假设是基于两年间隔后 SarQoL 评分的变化与短期表格 36(SF-36)和欧洲五维健康量表(EQ-5D)评分的变化之间的相关性。这种技术将反应能力视为一种纵向有效性。此外,还计算了标准化反应均值,以比较不同问卷测量的变化量。
共纳入 42 名肌肉减少症受试者。样本的中位年龄为 72.9(68.9-78.8)岁,59.5%为女性,平均体重指数为 23.3(20.4-25.7)kg/m。观察到良好的反应能力,有九个假设中的八个得到证实,远高于 75%的确认阈值。总体 SarQoL 评分的标准化反应均值明显高于 SF-36 生理成分综合评分(p=0.005)、EQ-5D 效用指数(p<0.001)和欧洲五维健康量表视觉模拟评分(p=0.003)。
SarQoL 问卷检测随时间变化能力的首批数据表明,该问卷具有良好的反应能力。这与之前建立的心理测量学特性一起,证实了 SarQoL 问卷是评估肌肉减少症人群生活质量的一个相关工具。